 |
The Journal of Neuroscience, June 30, 2004, 24(26):5966-5973; doi:10.1523/JNEUROSCI.1150-04.2004
Previous Article | Next Article 
Cellular/Molecular
YB-1 and CTCF Differentially Regulate the 5-HTT Polymorphic Intron 2 Enhancer Which Predisposes to a Variety of Neurological Disorders
Elena Klenova,1
Alison C. Scott,2,3
Julian Roberts,1
Shaharum Shamsuddin,1,5
Elizabeth A. Lovejoy,3
Stephan Bergmann,6
Vivien J. Bubb,3,4
Hans-Dieter Royer,7 and
John P. Quinn2,3
1Department of Biological Sciences, University of Essex, Essex CO4 3SQ, United Kingdom, 2Physiology Laboratory, Departments of 3Human Anatomy and Cell Biology and 4Neurological Science, Medical School, University of Liverpool, Liverpool L69 3BX, United Kingdom, 5School of Health Sciences, University Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia, 6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, and 7Breast Cancer Research, Center of Advanced European Studies and Research, 53175 Bonn, Germany
The serotonin transporter (5-HTT) gene contains a variable number tandem repeat (VNTR) domain within intron 2 that is often associated with a number of neurological conditions, including affective disorders. The implications of this polymorphism are not yet understood, however, we have previously demonstrated that the 5-HTT VNTR is a transcriptional regulatory domain, and the allelic variation supports differential reporter gene expression in vivo and in vitro. The aim of this study was to identify transcription factors responsible for the regulation of this VNTR. Using a yeast one-hybrid screen, we found the transcription factor Y box binding protein 1 (YB-1) interacts with the 5-HTT VNTR. Consistent with this, we demonstrate in a reporter gene assay that the polymorphic VNTR domains differentially respond to exogenous YB-1 and that YB-1 will bind to the VNTR in vitro in a sequence-specific manner. Interestingly, the transcription factor CCTC-binding factor (CTCF), previously shown to interact with YB-1, interferes with the ability of the VNTR to support YB-1-directed reporter gene expression. In addition, CTCF blocks the binding of YB-1 to its DNA recognition sequences in vitro, thus providing a possible mechanism of regulation of YB-1 activation of the VNTR by CTCF. Therefore, we have identified YB-1 and CTCF as transcription factors responsible, at least in part, for modulation of VNTR function as a transcriptional regulatory domain. Our data suggest a novel mechanism that explains, in part, the ability of the distinct VNTR copy numbers to support differential reporter gene expression based on YB-1 binding sites.
Key words: CTCF; YB-1; 5-HTT; VNTR; affective disorders; transcription
Received March 29, 2004;
revised May 11, 2004;
accepted May 13, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
J. Zlatanova and P. Caiafa
CTCF and its protein partners: divide and rule?
J. Cell Sci.,
May 1, 2009;
122(9):
1275 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Roberts, A. C. Scott, M. R. Howard, G. Breen, V. J. Bubb, E. Klenova, and J. P. Quinn
Differential Regulation of the Serotonin Transporter Gene by Lithium Is Mediated by Transcription Factors, CCCTC Binding Protein and Y-Box Binding Protein 1, through the Polymorphic Intron 2 Variable Number Tandem Repeat
J. Neurosci.,
March 14, 2007;
27(11):
2793 - 2801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Chernukhin, S. Shamsuddin, S. Y. Kang, R. Bergstrom, Y.-W. Kwon, W. Yu, J. Whitehead, R. Mukhopadhyay, F. Docquier, D. Farrar, et al.
CTCF Interacts with and Recruits the Largest Subunit of RNA Polymerase II to CTCF Target Sites Genome-Wide
Mol. Cell. Biol.,
March 1, 2007;
27(5):
1631 - 1648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gelfand, A. Rodriguez, and G. Benson
TRDB--The Tandem Repeats Database
Nucleic Acids Res.,
January 12, 2007;
35(suppl_1):
D80 - D87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Torrano, J. Navascues, F. Docquier, R. Zhang, L. J. Burke, I. Chernukhin, D. Farrar, J. Leon, M. T. Berciano, R. Renkawitz, et al.
Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism
J. Cell Sci.,
May 1, 2006;
119(9):
1746 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Miao, L. Hu, P. J. Scrivens, and G. Batist
Transcriptional Regulation of NF-E2 p45-related Factor (NRF2) Expression by the Aryl Hydrocarbon Receptor-Xenobiotic Response Element Signaling Pathway: DIRECT CROSS-TALK BETWEEN PHASE I AND II DRUG-METABOLIZING ENZYMES
J. Biol. Chem.,
May 27, 2005;
280(21):
20340 - 20348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fuke, N. Sasagawa, and S. Ishiura
Identification and Characterization of the Hesr1/Hey1 as a Candidate trans-Acting Factor on Gene Expression through the 3' Non-Coding Polymorphic Region of the Human Dopamine Transporter (DAT1) Gene
J. Biochem.,
February 1, 2005;
137(2):
205 - 216.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|